SCITERIONSCITERIONSCITERIONSCITERION
  • About
  • Culture
  • Join
  • Blog
  • Contact
✕
Championing medical education with Sciterion
25 July 2022
Visual Experience in Medical Education – an evolving creative approach
14 February 2023

Precision versus personalised medicine – is there a difference?

Published by Talent & People on 14 November 2022
Categories
  • Uncategorised
Tags
By Mark Smith, Senior Medical Manager and Hamed Khan, Associate Medical Manager

In recent years, we have witnessed the emergence of therapies with more precise pharmacological targets. Taking an example from oncology, traditional chemotherapy relies on the principle of cytotoxicity. By prevention of cell proliferation through inhibition of various phases of the cell cycle, non-targeted termination of cells was the first pharmacological method of treating cancer. Whilst various agents from this era of anticancer therapy were effective, this was a non-specific, ‘shotgun’ approach, resulting in the death of non-cancerous cells as well. For this reason, chemotherapy is well-known for its propensity to cause numerous adverse events, including alopecia, nausea, and blood dyscrasias.1 To date, healthcare professionals must tread carefully when balancing disease control with unacceptable (and potentially fatal) toxicities associated with cytotoxic chemotherapy.

The emergence of drugs with higher selectivity or specificity to pharmacological targets has altered the landscape of cancer therapy, and modern medicine as a whole. ‘Targeted therapy’ is a broad term that often refers to the use of drugs that target specific proteins, cell surface molecules, or genes.2 The concept of targeted therapy allows for improved efficacy and fewer adverse events due to higher selectivity and/or specificity. Newer molecules have advantages as targeted therapy in that their size allows them to pass easily through cell membranes to reach intended intracellular targets. Some are designed so that highly specific antigenic targeting allows for precise immune-mediated cell destruction.3,4,5

Photo by Volodymyr Hryshchenko on Unsplash

Another term – ‘precision medicine’ – is often used to refer to medicines tailored to the individual in accordance with their genes, environment and lifestyle.6 This can apply at a diagnostic and predictive level, for example when selecting for cancer screening or cardiac risk assessments based on family history. Precision medicine can also apply at a therapeutic level, as seen in various cancers where biomarkers are identified to detect the presence of certain tumour cells and identify targets for anticancer therapy.

‘Personalised medicine,’ is sometimes used interchangeably with ‘precision medicine’. However, whilst many modern agents are indeed precise, with high selectivity and specificity for pharmacological targets, the question remains whether these approaches are truly personalised. The word ‘personalised’ implies that treatment is uniquely tailored to be specific to the patient, which is untrue for most targeted therapies. Interestingly, it is now possible to collect a patient’s immune cells, reprogram them to target antigens associated with cancerous cells, and then reintroduce them to the patient. These modified immune cells are then able to recognise the tumour cells and direct an immune response whereby facilitating their elimination.7,8 This is arguably an example of personalised therapy, in that the genetically engineered cells are unique to each patient. This technology could be extended out of the oncological setting9, although the benefit-risk ratio would need to be considered, as such therapies are costly, time-consuming, and associated with potentially life-threatening side effects.8

Great strides have also been made in diagnostics via molecular testing, with whole-genome sequencing and next-generation sequencing becoming more readily available.10 These newer technologies have greater sensitivity compared with traditional single gene sequencing techniques.

Whilst whole-genome sequencing offers considerable diagnostic benefits for patients, there remain considerable barriers to its widespread implementation in clinical practice, including lack of reimbursement, limited accessibility, and inadequate standardisation of processes.11 As these components improve, a personalised approach to a greater number of diseases will become more accessible. This might even extend to encompass a more holistic approach to healthcare. For example, we might be able to pre-empt if a patient is genetically more susceptible to certain side effects and tailor management, as necessary.

Precision therapy may already be here, but so too are the foundations of truly personalised medicine.

References

  1. NICE. BNF. Cytotoxic Drugs. Available at: https://bnf.nice.org.uk/treatment-summaries/cytotoxic-drugs. Accessed November 2022
  2. Cancer.net. What is targeted therapy? Available at: https://www.cancer.net/navigating-cancer-care/how-cancer-treated/personalized-and-targeted-therapies/what-targeted-therapy. Accessed November 2022
  3. UptoDate. Overview of therapeutic monoclonal antibodies. Available at: https://www.uptodate.com/contents/overview-of-therapeutic-monoclonal-antibodies?search=monoclonal%20antibodies&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H2824611726. Accessed November 2022
  4. Cancer Research UK. Monoclonal antibodies. Available at: https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/immunotherapy/types/monoclonal-antibodies. Accessed November 2022
  5. AstraZeneca. Small Molecules. Available at: https://www.astrazeneca.com/r-d/next-generation-therapeutics/small-molecule.html. Accessed November 2022
  6. US FDA. Precision Medicine. Available at: https://www.fda.gov/medical-devices/in-vitro-diagnostics/precision-medicine. Accessed November 2022
  7. Marshall CR, et al. Genome Med. 2020;27:48.
  8. ESMO Daily Reporter. CAR-T-cell therapy. Available at: https://dailyreporter.esmo.org/esmo-congress-2021/opinions/car-t-cell-therapy-the-ultimate-personalised-treatment. Accessed November 2022
  9. Qin VM, et al. Cancers (Basel). 2021;13:404
  10. Petersen BS, et al. BMC Genet. 2017;18:14
  11. Panell M, et al. JCO Precis Oncol. 2019;3:1–9
Share
15

Find

SCITERION

Ferry Works
Summer Road
Thames Ditton
Surrey, UK
KT7 0QJ
enquiries@sciterion.com
+44 203 675 3975

Ask

Gabi Cutayar
Managing Director
gabi.cutayar@sciterion.com
+44 (0) 203 675 3969

© 2021 Sciterion. All Rights Reserved. Terms of use | Data protection policy | Cookie policy

Cookie Settings
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Click "Cookie Settings" to provide a controlled consent. Read our cookie policy
Cookie SettingsAccept AllReject All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_69063891_11 minuteSet by Google to distinguish users.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo